Deadly but necessary

August 2016

 

Here’s an interesting trivia question: what animal kills more human beings every year than any other?  The shark?  The lion?  Rhino? 

The answer is the mosquito, and the statistics are not even close.  Over 400,000 people were killed last year by mosquito-borne malaria.  Mosquitos carry four different encephalitis viruses, plus the West Nile virus—and most recently, the Zika outbreak that is threatening attendees at the Rio Olympics. 

But that begs a question: why do we tolerate this annoyance—and killer—in our midst?  Scientists who once relied on DDT and other crude chemical poisons now have powerful genetic eradication tools at their disposal, which make it possible to create infertile males who are released to mate with healthy females—and eliminate a generation of offspring.  Rinse, lather, repeat and suddenly a species has been removed from the local area.  An experiment in the Cayman Islands resulted in a 96% reduction in the mosquito population. 

There are several reasons why scientists are hesitating.  The first is that only 200 out of roughly 3,000 varieties of mosquito actually bite humans and animals, and only a few of those are capable of carrying deadly diseases.  Mosquitos are important pollinators in many ecosystems, and they represent an important part of the food chain.  Moreover, even the species that annoy you don’t do it for most of their lives.  Only female mosquitos seek out blood, and only because they need extra nutrition in the time right before they lay their eggs.   

Many of us live in climates where the mosquitos don’t carry dangerous diseases.  If you live in a moist, tropical environment, or plan to visit one, then your best bet is to use a repellant that contains one of the active ingredients recommended by the Centers for Disease Control and Prevention: DEET (Off!; Cutter, Sawyer, Ultrathon), Picaridin (Cutter Advanced, Skin So Soft Bug Guard, Autan), Oil of lemon eucalyptus (Repel), para-menthanediol, or IR3535 (SkinSmart).  And be thankful that you live in a country where malaria has largely been eradicated.   

Sincerely,

Edward J. Kohlhepp, Jr., CFP®, MBA
President 

Edward J. Kohlhepp, CFP®, ChFC, CLU, CPC, MSPA

Founder & CEO

 

http://www.facebook.com/pages/Kohlhepp-Investment-Advisors/143204745739600

 

Please contact us whenever there are any changes to your financial situation, personal situation or investment objectives.

 

 

 

 

This material was prepared by BobVeres.com., and does not necessarily represent the views of the presenting party, nor their affiliates. This information has been derived from sources believed to be accurate. Please note - investing involves risk, and past performance is no guarantee of future results. The publisher is not engaged in rendering legal, accounting or other professional services. If assistance is needed, the reader is advised to engage the services of a competent professional. This information should not be construed as investment, tax or legal advice and may not be relied on for the purpose of avoiding any Federal tax penalty. This is neither a solicitation nor recommendation to purchase or sell any investment or insurance product or service, and should not be relied upon as such. All indices are unmanaged and are not illustrative of any particular investment.

  

Sources:   

http://rense.com/general28/mosded.htm

 http://www.cdc.gov/features/stopmosquitoes/

 https://www.washingtonpost.com/news/speaking-of-science/wp/2016/08/01/dear-science-why-cant-we-just-get-rid-of-all-the-mosquitoes/?tid=sm_tw

News from Kohlhepp Investment Advisors, Ltd.
Stocks & Presidential Elections

Archived Newsletters


Investment Updates

  • Stocks Closed At A Record High

    The Standard & Poor’s 500 stock index closed Friday at a new all–time high,  ending the first quarter of the year with a gain of 10%. That’s as much as large-company stocks averaged annually  since 1926.

    Read more >>

  • Read More

Newsletters Sign Up

Account Login

Contact Info

Kohlhepp Investment Advisors, Ltd.
3655 Route 202, Suite 100
Doylestown, PA 18902
Phone: 215-340-5777
Fax: 215-340-5788
Email: Info@KohlheppAdvisors.com

Securities offered through Cambridge Investment Research, Inc. a Registered Broker/Dealer, Member FINRA/SIPC. Investment Advisory Services offered through Kohlhepp Investment Advisors, Ltd., a Registered Investment Advisor. Kohlhepp Investment Advisors, Ltd. and Cambridge Investment Research Advisors, Inc. are not affiliated.

Due to various state regulations and registration requirements concerning the dissemination of information regarding investment products and services, we are currently required to limit access of the following pages to individuals residing in states where we are currently registered. We are licensed in the following states: AZ, CA, CO, DE, FL, GA, IN, KY, LA, MA, MD, NC, NJ, NY, OR, PA, RI, SC, TX, VA, VT, WA


Check the background of this firm on FINRA's BrokerCheck